Table 3

Variations in the average number of packages prescribed

Experimental groupPlacebo groupControl group
RR95% CIRR95% CIRR95% CI
RR: relative reduction in the number of packages between the six months before and the six months after intervention.
Aceclofenac−29.34−42.22 to −16.46−19.59−30.18 to −9.00−22.85−33.84 to −11.86
Diclofenac−9.06−17.18 to −0.94−11.78−20.37 to −3.19−16.55−26.28 to −6.82
Meloxicam−25.48−37.81 to −13.15−13.15−22.16 to −4.14−1.17−3.99 to 1.65
Piroxicam−18.52−29.51 to −7.53−19.49−30.06 to −8.92−28.23−40.02 to −16.44
Tenoxicam−22.59−34.42 to −10.76−9.78−17.70 to −1.8614.445.22 to 23.66
Total−15.82−26.14 to −5.50−14.11−23.40 to −4.82−14.11−23.23 to −4.99